The Effect Of Fesoterodine On Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions

Urinary Bladder, Overactive

Interventions

DRUG

warfarin

Single Dose Warfarin 25 mg on Day 1

DRUG

Warfarin plus Fesoterodine

Fesoterodine 8 mg ER tablets QD for 9 Days and Single Dose Warfarin 25 mg on Day 3

Trial Locations (1)

Pfizer Investigational Site, New Haven